James M. Detore

Chief Financial Officer, bluebird bio.

Companies

CG Oncology, Inc.Chief financial officer Apr 16, 2026 to now¹
CG Oncology, Inc.Officer Nov 24, 2025 to now²
Proteostasis Therapeutics (United States)Officer Aug 8, 2016 to Aug 8, 2016³
bluebird bioChief financial officer Nov 10, 2014 to Dec 3, 2014⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCG Oncology, Inc., Chief financial officer
2
SEC EDGARCG Oncology, Inc., Officer
3
SEC EDGARProteostasis Therapeutics (United States), Officer
4
SEC EDGARbluebird bio, Chief financial officer